Clinical trial
Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With…
NCT00365768 · Columbia University, Other · Completed
Key facts
| NCT number | NCT00365768 |
|---|---|
| Title | Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors |
| Official title | A Pilot Study Investigating the Effects of Glutamine and Vincristine-Induced Neuropathy in Pediatric Patients With Cancer |
| Lead sponsor | Columbia University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer, Leukemia, Lymphoma, Neurotoxicity, Peripheral Neuropathy, Sarcoma |
| Intervention type | Drug, Other |
| Interventions | Glutamine, Placebo |
| Enrollment | 56 |
| Start date | Oct 1, 2004 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | Aug 17, 2006 |
| Last update posted | Sep 9, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: